USPTO serial 79398746
INFORM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- GANESH, HARINI
- Law office
- TMO LAW OFFICE 122
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with INFORM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Nancy Kennedy
Nancy Kennedy Stites & Harbison PLLC71 Raymond RoadWest Hartford, CT 06107United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical devices for use in pathology, namely, non-invasive medical imaging devices for enabling digital slide-free real-time decision-making by pathologists at the point-of-sample contact, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Medical apparatus for analysis, namely, non-invasive medical imaging devices for enabling real-time point-of-care decision-making without slide preparation in the field of pathology, non-invasive digital handheld microscopes for enabling real-time point-of-care decision-making in the field of pathology without slide preparation, non-invasive microscopic medical imaging devices for enabling real-time point-of-care decision-making in the field of pathology without tissue processing and without slide preparation, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Medical apparatus for pathology analysis delivering instant, non-invasive microscopic imaging without tissue processing or slide preparation, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Apparatus for medical diagnostic purposes, namely, non-invasive medical imaging devices and digital handheld microscopes for use in the field of pathology to deliver real-time digital results, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Apparatus for medical purposes, namely, non-invasive microscopic medical imaging devices and digital handheld microscopes for use in the fields of laboratory medicine, pathology, point-of-care treatment and digital pathology, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Diagnostic apparatus for medical purposes, namely, non-invasive microscopic medical imaging devices and digital handheld microscopes for use in the fields of laboratory medicine, pathology, point-of-care treatment and digital pathology, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Medical instruments incorporating fiber optics and optical fibers for diagnostic use, namely, non-invasive microscopic medical imaging devices and digital handheld microscopes for use in the fields of laboratory medicine, pathology, point-of-care treatment and digital pathology without tissue processing or slide preparation, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring; Medical endoscopes and parts and accessories therefor, namely, probes, disposable sterile sheaths, sterilisation accessories, caps for probes, probe handles, probe holders, all of the aforementioned goods not being dental apparatus and not for use in blood glucose monitoring | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 29, 2026 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 29, 2026 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 11, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 26, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 26, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 15, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 15, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 15, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 17, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 17, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 17, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 16, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 16, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 16, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 16, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 17, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 4, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 3, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 3, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 3, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |